The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with carboplatin-paclitaxel after multiple lines of treatment.
 
Elisa María Fernández Pérez
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Accord Healthcare; Merck Serono; Novartis; Pfizer; Sanofi
 
Isabel Beltrán Guerra
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Janssen; Merck; Pfizer; Pierre Fabre
 
Adrian Sánchez Vegas
Honoraria - Pfizer
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
 
Carlos Enrique Robles
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Expert Testimony - AstraZeneca; GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Gloria Lourenzo Aguilera
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer; Pierre Fabre
 
Marta Fernández Carcaño
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Grunenthal; MSD Oncology; Novartis
 
Carlos Ayala De Miguel
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Eisai; MSD Oncology
 
Sebastián Díaz López
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Merck; MSD Oncology
 
Guillermo García González
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Grunenthal; Novartis
 
Leonid Bachurin
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Grunenthal; Novartis; Pfizer
 
Javier Rico López
No Relationships to Disclose
 
Jose Fuentes Pradera
Consulting or Advisory Role - MSD Oncology; Roche/Genentech
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Medarex; Pfizer; Sanofi; Takeda
Research Funding - BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Other Relationship - Pfizer
 
Jeronimo Jimenez Castro
Honoraria - Merck; SERVIER
Research Funding - BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen
 
María Rodríguez de la Borbolla
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Novartis; Pfizer; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Novartis; Pfizer; Seagen
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
 
Pilar López Álvarez
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Novartis; Pfizer; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Novartis; Pfizer; Seagen
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
 
María José Gómez Reina
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche; SERVIER
 
Manuel Chaves Conde
Honoraria - Merck; MSD Oncology
Speakers' Bureau - Bristol-Myers Squibb; Merck; MSD Oncology
Research Funding - Adlai Nortye (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck; MSD Oncology
 
Eva Fernández Parra
Consulting or Advisory Role - Ipsen Advisory Board, Personal
Speakers' Bureau - - Bayer Invited Speaker, Personal; - BMS Invited Speaker, Personal -; Merck Invited Speaker, Personal.
Research Funding - BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Merck (Inst); Roche/Genentech (Inst)